Nabil F. Saba, MD, FACP

Professor, Hematology & Medical Oncology

Emory University School of Medicine

Professor, Department of Otolaryngology

Emory University School of Medicine

Director, Head and Neck Medical Oncology Program

Winship Cancer Institute of Emory University

Office: Emory University Hospital Midtown


For all patient inquiries or appointment requests, please dial (404) 778-1900. Fax patient records to (404) 778-2177.


Dr. Nabil Saba is a recognized expert on immunotherapy and various systemic therapy modalities for head and neck cancer. His work is focused on translational research and the study and development of novel therapeutic agents in head and neck and esophageal cancer. He leads several clinical trials and chairs national as well as investigator initiated multi-institution studies focusing on novel approaches for treating these diseases.

Dr. Saba is the elected Chair of the National Cancer Institute's task force for recurrent metastatic head and neck cancer, and chairs the Rare Tumors Task Force of the National Cancer Institute's Head and Neck Cancer Steering Committee. Prior to joining the faculty at Emory University, he was recognized for his outstanding contribution to the fellowship program at the University of Minnesota. Dr. Saba is also an active member of the Eastern Cooperative Oncology Group and NRG Oncology Head and Neck Cancer Core Committee and served on the American College of Radiology appropriateness criteria panel for head and neck cancer.

Dr. Saba earned his Medical Degree from the American University of Beirut Medical School. He completed a Residency in Internal Medicine at Tufts University School of Medicine in Boston, and a Clinical Fellowship in Hematology and Medical Oncology at Brown University School of Medicine. He also completed a Bone Marrow Transplant Fellowship at the University of Toronto Princess Margaret Hospital in Toronto, Canada.

Full Clinical Bio >>


Dr. Saba's research is focused on clinical and translational work in head and neck, and esophageal cancer. He has been the recipient of several NIH and industry funded grant support to study these malignancies. He is the recipient of funding from the NIH to examine novel genomic approaches for diagnosing HPV positive oropharyngeal cancers. He conducts and leads a large number of head and neck cancer clinical trials with a focus on biomarker endpoints.

Among Dr Saba's contributions is serving as a co-leader of project 4 of the previous Emory Head and Neck Cancer SPORE involving the application of nano-therapeutics-based therapy for treating advanced head and neck cancer and serving as a principal investigator of the recently submitted Emory Head and Neck Cancer SPORE Grant.


Dr. Saba has authored more than 150 multiple peer-reviewed articles, editorials, review papers, book chapters as well as two Uptodate chapters. He is editor of the textbook, "Esophageal Cancer; Prevention, Diagnosis and Treatment." He is associate editor for Head Neck and a member of the editorial board of Cancer, Oral Oncology, American Journal of Clinical Oncology and Cancers of the Head and Neck. He has been recognized as an outstanding reviewer for the journal, Cancer.

Clinical Trials

View clinical trials at Winship Cancer Institute